
---
title: '白云山：头孢丙烯分散片通过仿制药一致性评价'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=3492'
author: 证券时报网
comments: false
date: Fri, 15 Oct 2021 16:59:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=3492'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS600332" style="color: #2f67d1;text-decoration: none;" code="600332" target="_blank">白云山</a>(600332)10月15日晚间公告，分公司<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS600332" style="color: #2f67d1;text-decoration: none;" code="600332" target="_blank">白云山</a>制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，头孢丙烯分散片已通过仿制药质量和疗效一致性评价。</p>

                  
</div>
            